BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study-Reference-Cited by-同舟云学术

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study

Published:2018-07-24 Issue:7 Volume:13 Page:e0201086
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kowalik Artur^ORCID,Siołek Monika^ORCID,Kopczyński Janusz,Krawiec Kamila,Kalisz Joanna,Zięba Sebastian,Kozak-Klonowska Beata,Wypiórkiewicz Elżbieta,Furmańczyk Jowita,Nowak-Ozimek Ewelina,Chłopek Małgorzata,Macek Paweł^ORCID,Smok-Kalwat Jolanta,Góźdź Stanisław

Funder

The study was supported by the Holycross Cancer Centre.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies;AC Antoniou;J Med Genet,2005

2. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status;J Gronwald;J Med Genet,2006

3. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation;GK Suthers;ANZ J Surg,2007

4. BRCA1-positive breast cancers in young women from Poland;J Lubinski;Breast Cancer Res Treat,2006

5. A high proportion of founder BRCA1 mutations in Polish breast cancer families;B Gorski;Int J Cancer,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement;Oncology in Clinical Practice;2024-08-21

2. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

3. The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients;Current Issues in Molecular Biology;2024-05-12

4. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing;Pathology - Research and Practice;2024-02

5. Systemic treatment in triple-negative breast cancer patients — standard and novel approaches;Oncology in Clinical Practice;2023-12-05